Slide 1: 2nd Quarter 2024 Earnings Release Supplemental Information
nd 2 Quarter 2024 Earnings Release Supplemental Information July 31, 2024
Slide 2: Safe Harbor: Forward Looking Statements
Safe Harbor Forward Looking Statements .This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, such as statements about our future plans, objectives, expectations, financial perform
Slide 3: Solid Q2 performance, in line with expectations
Q2 2024 Year-over-Year Solid Q2 performance, in line with expectations • We continue to deliver on expectations and we are executing on the transitions of the company's portfolio to higher REVENUE Non-GAAP DILUTED NET CASH PROVIDED BY value markets and products. ($M) EPS* OPERATING ACTIVITIES ($) ($
Slide 4: Q2 2024 Segment Performance: MedTech & Specialty Audio
Q2 2024 Segment Performance MedTech & Specialty Audio REVENUE Non-GAAP GROSS PROFIT MARGIN* ($M) (%) • Revenue was down slightly versus the year ago period driven by lower demand in 53.5 54.6 the specialty audio market. 60.6 59.5 • Non-GAAP Gross Profit Margin increased year-over- year driven by imp
Slide 5: Q2 2024 Segment Performance: Precision Devices
Q2 2024 Segment Performance Precision Devices • Revenue up year-over-year driven by the acquisition of REVENUE Non-GAAP Cornell partially offset by GROSS PROFIT MARGIN* lower shipments of high- ($M) (%) performance capacitors into the distribution channels and industrial end markets. 39.7 74.1 37.2
Slide 6: Q2 2024 Segment Performance: Consumer MEMS Microphones
Q2 2024 Segment Performance Consumer MEMS Microphones REVENUE Non-GAAP GROSS PROFIT MARGIN* • Revenue increased year- ($M) (%) over-year due to increased consumer demand primarily 71.1 33.6 in Ear and IOT end markets. 64.6 28.1 • Non-GAAP Gross Profit Margin decreased from the prior year primarily d
Slide 7: Outlook: Q3 2024 Guidance
Outlook Q3 2024 Guidance GAAP ADJUSTMENTS NON-GAAP Revenue $210 to $220 million — $210 to $220 million Diluted earnings per share $0.20 to $0.24 $0.09 $0.29 to $0.33 Net cash provided by operating activities $35 to $45 million — $35 to $45 million Q3 2024 GAAP results are expected to include approxi
Slide 8: Appendix
« knowles Appendix
Slide 9: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures Quarter Ended June 30, (in millions, except per share amounts) 2024 2023 Revenues $ 204.7 $ 173.0 Gross profit $ 77.6 $ 73.7 Notes: Gross profit margin 37.9 % 42.6 % (1) Stock-based compensation expense 0.5 0.7 Production trans
Slide 10: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures Quarter Ended June 30, (in millions, except per share amounts) 2024 2023 Notes: Net (loss) earnings $ (259.3) $ 13.6 (4) The non-GAAP reconciling adjustments are those adjustments made to Interest expense, net 4.6 0.8 reconcile
Slide 11: Historical Segment Data
Historical Segment Data Precision Devices MedTech & Specialty Audio Consumer MEMS Microphones Quarter Ended Quarter Ended Quarter Ended June 30, March 31, December 31, September 30, June 30, June 30, March 31, December 31, September 30, June 30, June 30, March 31, December 31, September 30, June 30,
Slide 12: Historical Segment Data
Historical Segment Data Precision Devices MedTech & Specialty Audio Consumer MEMS Microphones Quarter Ended Quarter Ended Quarter Ended June 30, March 31, December 31, September 30, June 30, June 30, March 31, December 31, September 30, June 30, June 30, March 31, December 31, September 30, June 30,
Slide 13: Reconciliation of Segment EBIT to Consolidated Net Earnings
Reconciliation of Segment EBIT to Consolidated Net Earnings Quarter Ended June 30, March 31, December 31, September 30, June 30, (in millions) 2024 2024 2023 2023 2023 (Loss) earnings before interest and income taxes Precision Devices $ 4.2 $ (2.1) $ 3.4 $ 6.1 $ 4.8 MedTech & Specialty Audio 24.0 22
Slide 14: Reconciliation of Net Earnings to Adjusted EBITDA
Reconciliation of Net Earnings to Adjusted EBITDA Quarter Ended June 30, March 31, December 31, September 30, Trailing (in millions) 2024 2024 2023 2023 12 Months Net (loss) earnings $ (259.3) $ 2.5 $ 47.4 $ 16.6 $ (192.8) Interest expense, net 4.6 4.4 3.2 0.6 12.8 Provision for (benefit from) incom
Slide 15: Reconciliation of Net Debt and Net Debt Leverage Ratio Calculation
Reconciliation of Net Debt and Net Debt Leverage Ratio Calculation June 30, 2024 (in millions) Current maturities of long-term debt $ 48.8 Long-term debt 212.4 Total debt 261.2 Less: Cash and cash equivalents (84.0) Net debt $ 177.2 Net debt $ 177.2 Trailing 12 Month Adjusted EBITDA $ 156.6 Net debt
Slide 16: Thank you
Thank you 16